Search Browse Earnings

ENZON PHARMACEUTICALS, INC.

OTC:ENZN

Biological Products, (No Diagnostic Substances)·CRANFORD, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

ENZON PHARMACEUTICALS, INC. — SlamSEC

Revenue

$26,000

+0.0% YoY

FY 2025

Adj. EBITDA

-$1.1M

-4211.5% margin

FY 2025

Net Income

$778,000

2992.3% margin

FY 2025

EPS (Diluted)

-$0.01

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$46.9M

FY 2025

Total Debt

$231.7M

FY 2013

Net Debt

$184.8M

FY 2013

Enterprise Value

—

Debt / EBITDA

-168.8x

FY 2025

EV / EBITDA

—

Employees

—

Enzon Pharmaceuticals, Inc. is a pharmaceutical company.